|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to the transfer of unused long-acting reversible |
|
contraceptive products under Medicaid and the Healthy Texas Women |
|
program. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter B, Chapter 531, Government Code, is |
|
amended by adding Section 531.0742 to read as follows: |
|
Sec. 531.0742. TRANSFER OF UNUSED LONG-ACTING REVERSIBLE |
|
CONTRACEPTIVE PRODUCT. (a) In this section: |
|
(1) "Healthy Texas Women program" means a program |
|
operated by the commission that is substantially similar to the |
|
demonstration project operated under former Section 32.0248, Human |
|
Resources Code, and that is intended to expand access to preventive |
|
health and family planning services for women in this state. |
|
(2) "Long-acting reversible contraceptive product" |
|
means a method of birth control that provides effective |
|
contraception for an extended period without requiring user action. |
|
The term includes an injection, intrauterine device, and subdermal |
|
contraceptive implant. |
|
(b) In accordance with commission rules, a health care |
|
provider under Medicaid or the Healthy Texas Women program may |
|
transfer to a Medicaid or Healthy Texas Women program recipient a |
|
long-acting reversible contraceptive product prescribed by the |
|
provider to another recipient if: |
|
(1) the long-acting reversible contraceptive product: |
|
(A) was not delivered to or used by the recipient |
|
to whom the contraceptive product was initially prescribed; |
|
(B) is contained in the contraceptive product's |
|
original packaging and that packaging is unopened; and |
|
(C) is prescribed to and is medically appropriate |
|
and not contraindicated for the recipient to whom the contraceptive |
|
product is being transferred; and |
|
(2) at the time of the transfer: |
|
(A) the contraceptive product has been in the |
|
health care provider's possession for at least 12 weeks following |
|
the date of the original prescription for the product; or |
|
(B) the health care provider has written |
|
confirmation that the recipient to whom the contraceptive product |
|
was initially prescribed no longer wishes to receive or use the |
|
product. |
|
SECTION 2. Not later than March 31, 2020, the executive |
|
commissioner of the Health and Human Services Commission shall |
|
adopt rules necessary to implement Section 531.0742, Government |
|
Code, as added by this Act. |
|
SECTION 3. If before implementing any provision of this Act |
|
a state agency determines that a waiver or authorization from a |
|
federal agency is necessary for implementation of that provision, |
|
the agency affected by the provision shall request the waiver or |
|
authorization and may delay implementing that provision until the |
|
waiver or authorization is granted. |
|
SECTION 4. This Act takes effect September 1, 2019. |